𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lower HER-2/chromosome enumeration probe 17 ratio in cytologic HER-2 fluorescence in situ hybridization for breast cancers

✍ Scribed by Itoh, Hitoshi ;Miyajima, Yoko ;Umemura, Shinobu ;Osamura, Robert Y.


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
251 KB
Volume
114
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background:

Fluorescence in situ hybridization (fish) is the gold standard for assessing her-2 status for breast cancers, and paraffin-embedded tissue sections are used routinely for her-2 fish. cytologic samples also are used, but to the authors' knowledge, little is known regarding the reliability of these samples. the objective of this study was to elucidate the usefulness of cytologic specimens for her-2 fish testing.

Methods:

Histologic and cytologic specimens from 32 patients with invasive ductal carcinoma of the breast were subjected to comparative analysis of her-2 status by fish. fish was performed by using a pathvysion her-2 dna probe kit according the manufacturer's instructions. the signal ratios of chromosome enumeration probe 17 (cep17) and her-2 were estimated and compared. in 15 cytologic specimens, the distance between signals (her-2 and cep17) and the nearest nuclear membrane were measured by using 3-dimensional image analysis and confocal microscopy.

Results:

Cytologic and histologic fish results were compared. signal ratios of her-2/cep17 were lower in cytologic specimens from 26 of 32 patients compared with the histologic material. three-dimensional image analysis demonstrated that the distance between the cep17 signal and the nuclear membrane was shorter than the distance between the her-2 gene and the nuclear membrane.

Conclusions:

The current results demonstrated that cep17 could be lost more easily through histologic sectioning compared with the cytology results, because cep17 is closer to the nuclear membrane. fish analysis in cytologic specimens produced more accurate her-2/cep17 ratios, because the whole nucleus was subjected to fish testing, compared with matched histologic specimens.


πŸ“œ SIMILAR VOLUMES


HER-2/neu amplification by fluorescence
✍ Bozzetti, Cecilia ;Personeni, Nicola ;Nizzoli, Rita ;Guazzi, Annamaria ;Flora, M πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 83 KB

BACKGROUND. Amplification of the HER-2/neu oncogene has been proposed as a target for antibody-based therapies and as a predictor of chemoresponsiveness in advanced breast carcinoma. Few studies have concentrated on HER-2/neu gene evaluation by fluorescence in situ hybridization (FISH) on distant me

HER-2/NEU gene amplification in breast i
✍ Jeffrey G. Moore; Viet To; Shobha J. Patel; Nour Sneige πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 203 KB πŸ‘ 2 views

Fluorescence in situ hybridization (FISH) is a validated method for detection of HER-2/neu gene amplification and was recently approved by the FDA for diagnostic use in paraffin-embedded tissue. Its use in cytologic specimens, however, has not been investigated. To see whether HER-2/neu gene amplifi

Quantitative HER2 protein levels predict
✍ Allan Lipton; Wolfgang J. KΓΆstler; Kim Leitzel; Suhail M. Ali; Jeff Sperinde; Jo πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 492 KB πŸ‘ 2 views

## Abstract ## BACKGROUND: Only a portion of breast cancer patients currently selected for trastuzumab therapy respond. ## METHODS: Using a novel assay (HERmark) to quantify total human epidermal growth factor receptor 2 (HER2) expression, the authors examined outcomes in 102 trastuzumab‐treated

Comprehensive immunohistochemical analys